China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...

The HHS issues more details on President Donald Trump's plans to lower U.S. drug prices through most-favored-nation drug ...

Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all ...

While President Donald Trump may wish he lives and works in the Hogwarts School of Witchcraft and Wizardry and has Harry ...

The EO states that while American citizens represent only 5% of the global population, they fund around 75% of global ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Donald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines ...

The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next ...

Pharmaceuticals represent a critical component of modern healthcare, yet their costs remain a major source of concern for governments, private insurers, and especially consumers. In recent years ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...